Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
D000284:Administration, Oral; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004206:Disopyramide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D011342:Procainamide / Q000008:administration & dosage / Q000627:therapeutic use*; D011725:Pyridines / Q000009:adverse effects*; D011802:Quinidine / Q000008:administration & dosage / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced*; D014693:Ventricular Fibrillation / Q000139:chemically induced*; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy*
D011725:Pyridines; D008012:Lidocaine; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide